Maria Silvia Cona

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHealth informatics and information systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 26, 2026
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast Units.

Nicla La Verde, Luisa Brogonzoli, Maria Silvia Cona

|Jun 27, 2024
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.

Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri

|Dec 15, 2023
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients.

Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri

|Apr 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.

Maria Silvia Cona, Agostino Riva, Davide Dalu

|Oct 26, 2022
Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System.

Maria Silvia Cona, Anna Maria Mancuso, Antonio Russo

|Sep 03, 2022
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.

Nicla La Verde, Agostino Riva, Maria Silvia Cona

Pageof 2

Frequent Collaborators

4 joint publications

Nicla La Verde

3 joint publications

Lorenzo Ruggieri

2 joint publications

Davide De Francesco

1 joint publications

Davide Dalu